OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect</p>
Huining Tian, Xiaoyu Zhu, You Lv, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 5957-5974
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
Xueying Zhao, Jin Chen, Shangqi Yin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 39

The role of N-glycosylation modification in the pathogenesis of liver cancer
Mengyu Hu, Rui Zhang, Jiaren Yang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 27

Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Philippe Icard, Luca Simula, Zherui Wu, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100790-100790
Open Access | Times Cited: 35

LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis
Chuanjiang Liu, Kequan Xu, Jiayin Liu, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 14

The Research Progress of Mitochondrial Transplantation in the Treatment of Mitochondrial Defective Diseases
Cuilan Hu, Zheng Shi, Xiongxiong Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1175-1175
Open Access | Times Cited: 5

Research Progress of Warburg Effect in Hepatocellular Carcinoma
Yanguang Yang, Yuting Gao, Yajun Xiong, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 5

Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma
Qing Peng, Liyuan Hao, Yinglin Guo, et al.
Journal of Natural Medicines (2022) Vol. 77, Iss. 1, pp. 28-40
Closed Access | Times Cited: 20

Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development
Monika Gjorgjieva, Cyril Sobolewski, Anne‐Sophie Ay, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 4, pp. 170-170
Open Access | Times Cited: 28

Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma
Kyoko Oura, Asahiro Morishita, Tomoko Tadokoro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13590-13590
Open Access | Times Cited: 3

Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
Dan Chen, Ayinuer Aierken, Hui Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7

A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinoma
Zhihong Chen, Yiping Zou, Yuanpeng Zhang, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 11
Open Access | Times Cited: 16

Pien Tze Huang regulates phosphorylation of metabolic enzymes in mice of hepatocellular carcinoma
Jin‐Xia Lin, Shicong Wang, Wenliang Lan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6

Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies
Alaa Elmetwalli, Neamat H. Kamosh, Rania El Safty, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 6

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
María Luz Martínez‐Chantar, Matías A. Ávila, Shelly C. Lu
Cancers (2020) Vol. 12, Iss. 10, pp. 2729-2729
Open Access | Times Cited: 15

Mitochondrial Carriers and Substrates Transport Network: A Lesson from Saccharomyces cerevisiae
Alessandra Ferramosca, Vincenzo Zara
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8496-8496
Open Access | Times Cited: 13

Operando NMR metabolomics of a microfluidic cell culture
Genevieve Rogers, Sylwia J. Barker, Manvendra Sharma, et al.
Journal of Magnetic Resonance (2023) Vol. 349, pp. 107405-107405
Open Access | Times Cited: 5

Innate immune cells and their interaction with T cells in hepatocellular carcinoma (Review)
Guoqing Hong, Dong Cai, Jianping Gong, et al.
Oncology Letters (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 14

HBV DNA polymerase regulates tumor cell glycogen to enhance the malignancy of HCC cells
Xiaoqing Zhao, Chunqing Wang, Liqing Zhao, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 1

Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk Factors
Nicholas Dale D. Talubo, Po‐Wei Tsai, Lemmuel L. Tayo
Biology (2024) Vol. 13, Iss. 10, pp. 765-765
Open Access | Times Cited: 1

A Gluconeogenesis-Related Genes Model for Predicting Prognosis, Tumor Microenvironment Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma
Xilong Tang, Jianjin Xue, Jie Zhang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1907-1926
Open Access

Page 1 - Next Page

Scroll to top